Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance.

Biomedicines · 2023 · PMC10740911 · PMID 38137355

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

It was clear that by both assessment methods, CLDN9 is highly significant in distinguishing patients’ responses.

also in 132,142 other papers

marginally statistically significantno p-value reported

Patients who died of breast cancer and who developed breast cancer-related incidence had a raised level of the CLDN9 transcript, although these were marginally statistically significant.

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.